Quick Answer
IN8BIO, INC. reported Earnings Per Share Diluted of $4.44 (loss) per share for the year ending 2025.
- IN8BIO, INC. showed an increase of +74.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from IN8BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $1.00 (loss) per share | Q3 2021: $0.25 (loss) per share | Q1 2022: $0.33 (loss) per share | Q2 2022: $0.38 (loss) per share | Q3 2022: $0.34 (loss) per share | Q1 2023: $0.30 (loss) per share | Q2 2023: $0.27 (loss) per share | Q3 2023: $0.23 (loss) per share | Q1 2024: $0.20 (loss) per share | Q2 2024: $5.51 (loss) per share | Q3 2024: $4.49 (loss) per share | Q1 2025: $0.07 (loss) per share | Q2 2025: $1.24 (loss) per share | Q3 2025: $0.85 (loss) per share.
- Over the full 5 years of available data (2021 to 2025), IN8BIO, INC.'s Earnings Per Share Diluted has declined by 202.0%.
- Historical annual values: Fiscal year 2025: $4.44 (loss) per share | Fiscal year 2024: $17.05 (loss) per share | Fiscal year 2023: $1.00 (loss) per share | Fiscal year 2022: $1.36 (loss) per share | Fiscal year 2021: $1.47 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: